depending on sex. 5 For example, in females, E2 accelerates cutaneous wound healing without ischemia via estrogen receptor-β (ERβ), [6] [7] [8] whereas in males, E2 was reported to have a negative effect mediated by ERα. 9 This sexual divergence in wound healing seems to be multifactorial and strongly influenced by inflammation and MIF (Macrophage Inhibitory Factor). 5 Furthermore, testosterone and its metabolite, 5α-dihydrotestosterone, have also been shown to inhibit wound repair via an AR-mediated mechanism 10 through the inhibition of re-epithelialization 11 and the expression of matrix proteins and proteolytic factors. 12 This sex effect has not only been shown to impact on inflammatory processing but has also been observed in the vascular response to prolonged ischemia in arteriogenesis and angiogenesis, processes which allow tissue revascularization. It is now clear that, in females, ERα and not ERβ mediates most of the beneficial vascular actions of E2, 13 including the prevention of necrosis after cutaneous ischemia. 1, 14 In males, AR loss was found to impair angiogenesis in a mouse model of hindlimb ischemia, 4 an effect which was confirmed using a model of matrigel plugs and hindlimb ischemia in males but not in females. 15 However, in a rabbit model of chronic hindlimb ischemia, angiogenesis and arteriogenesis did not significantly differ between males and females. 16 Altogether, these data demonstrate the complexity of the actions of sex hormones in terms of their tissue-and context-specific roles. These studies seem to be largely limited by the presence of a combination of gonadal steroids in both the males and females which are being compared, which can confuse results. More conclusive results can be achieved by using gonadectomized animals treated or not with E2 or dihydrotestosterone. Indeed, AR can be activated both directly by testosterone and indirectly by its reduced metabolite dihydrotestosterone, which is a nonaromatizable AR activator. Testosterone can also indirectly activate ERs after its aromatization into E2.
Surprisingly, the effect of testosterone on ischemic skin repair and necrosis has never been reported. Thus, we sought to explore the role of these sex hormones (testosterone, E2, and dihydrotestosterone) in male mice using a mouse model of skin flap ischemia. We found that intact male mice were protected against skin necrosis, but that orchidectomized mice were not. In these mice, exogenous testosterone was able to restore the protection, revealing that, as observed in females, gonadic sex hormones play an important role. We then deciphered the mechanisms underlying this protection, in particular the specific roles of AR compared with ER. In contrast to wound healing, our results demonstrate that male mice are protected against skin necrosis by the complementary actions of estrogens and androgens, which act through independent mechanisms to promote both skin survival and revascularization.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Male Sex Hormones Such as Testosterone and Dihydrotestosterone Protect Male Mice From Skin Flap Necrosis
We first examined the impact of castration on skin flap necrosis in male mice using the well-described soft tissue ischemia model 1 ( Figure 1A and 1B). In castrated untreated C57BL/6 male mice, we observed severe and extended necrosis (desquamation, alopecia, and scab formation) within 1 week of surgery that was maximal in the distal part of the flap. At its maximum point on day 6, the necrosis accounted for 69.0±3.3% of the total flap area in castrated mice, whereas intact male were protected (26.3±3.9%; Figure 1C and 1D). Testosterone is the most abundant sex hormone in male mice, and castration dramatically decreased the amount of circulating serum testosterone (0.64±0.1 ng/mL in intact mice versus undetectable levels in castrated males; Figure I in the online-only Data Supplement).
We then looked at the effect of testosterone by treating castrated mice with a pellet releasing testosterone (7.5 mg/60 days) before performing skin flap surgery. Testosterone reduced skin flap necrosis in castrated male mice (21.5±4.8% at day 6 versus 69±2.9% for untreated castrated mice; P<0.001; Figure 1E ). To determine whether the action of testosterone through AR was direct or indirect after its reduction to dihydrotestosterone, we also treated a separate group of castrated C57BL/6 male mice with a pellet releasing dihydrotestosterone (7.5 mg/60 days; Figure 1F ). Male mice treated with dihydrotestosterone were also efficiently protected from necrosis compared with untreated animals (21.7±3.4% in dihydrotestosterone-treated versus 69.0±2.9% in castrated mice; P<0.001), and their recovery was faster in dihydrotestosterone-treated mice, with recovery on day 8 appearing more advanced than that observed in testosteronetreated mice. Seminal gland weights confirmed the efficiency of these hormonal treatments (12.7±1.3 mg for castrated mice, 151±10 mg for intact males, 266±10.9 mg for testosterone-treated mice, and 211±9.6 mg for dihydrotestosteronetreated mice; Figure I in the online-only Data Supplement). Similar results were obtained in male mice from another genetic background, that is FVB mice (12.6±7.4% for dihydrotestosterone-treated mice versus 62.5±7.4% for untreated castrated mice; P<0.001; Figure II in the online-only Data Supplement).
These data indicate that testosterone can prevent skin necrosis via its conversion into dihydrotestosterone and thus through its indirect action on AR, regardless of the genetic background. Testosterone can also have indirect effects on necrosis through the activation of ER after its aromatization into E2; therefore, we next treated castrated male mice with E2 ( Figure 2A and 2B). In these mice, necrosis was largely reduced, representing 21.6±4.1% (P<0.001) of the total area on day 6. Representative images from day 12 are shown ( Figure 2E , left). E2 can act through both ERα and ERβ, which are reported to be widely expressed in the skin, specifically in keratinocytes, hair follicles, fibroblasts, endothelial, and inflammatory cells. 8, 17 To address the contribution of each ER in the prevention of skin necrosis, the skin flap ischemia experiment was performed in ERα-knockout (ERα-KO) and ERβ-knockout (ERβ-KO) mice, in either the absence of E2 (castrated [CSX]) or after exogenous E2 supplementation (CSX+E2). Our results showed that the protective effect of E2 was still observed in ERβ-KO mice ( Figure 2C and 2E, middle), whereas high rates of necrosis similar to untreated castrated mice were obtained in castrated ERα-KO mice on day 6 (68.25±3.6% in CSX+E2 versus 62.25±9.5% in CSX mice; Figure 1D and 1E, right). Interestingly, intact male ERα-KO mice were also protected from cutaneous necrosis on day 6 (14.4±8.5%), showing the involvement of a mechanism other than E2, which strongly suggests a protective action of testosterone in these male ERα-KO mice ( Figure 1D ). Indeed, ER deficiency has also been shown to lead to a loss of negative feedback on the hypothalamic-pituitary axis, causing a significant increase in circulating estradiol and testosterone, 18 and we confirmed this as seminal gland weights were greater in ERα-KO mice than wild type (WT).
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Altogether, these data indicate that E2 prevents skin flap necrosis in male mice through ERα activation. Male sex hormones protect male mice from cutaneous skin ischemia. A, Experimental protocol: male mice were castrated at 5 wk of age and implanted, or not, with pellets releasing testosterone (7.5 mg, 60-d release) or dihydrotestosterone (DHT; 7.5 mg, 60-d release; Innovative Research of America, Sarasota, FL). Skin flap surgery was performed 2 wk later. B, Model of cutaneous skin surgery that led to ischemia and subsequent necrosis in the distal part of the skin flap. Percentages of necrosis were quantified by planimetry, measuring the area of necrosis on the day of analysis (green area) divided by the area of the skin flap on d 0 (red area). C, Percentages of necrosis were quantified on intact male or castrated C57BL6 mice. D, Representative photographs were shown on d 12 of castrated C57BL/6 mice vs intact male mice. E and F, Percentages of necrosis on castrated C57BL6 mice treated with (E) testosterone or (F) DHT. *P<0.05, **P<0.01, ***P<0.001.
Protective Effect Against Necrosis Is Also Mediated by AR Activation
To strengthen the importance of the AR activation on the male mice, we also used the Aromatase knockout (Ar-KO) mice that lack a functional aromatase enzyme and are unable to convert testosterone into estrogen. 19 Because this deletion causes an absence of production of estrogens, the actions of testosterone and of its converted metabolite (dihydrotestosterone) were blocked using the antiandrogen, the bicalutamide. This treatment in Ar-KO mice increases significantly skin necrosis when compared with WT mice (39.52±11%in Ar-KO versus 23.1±2.2% in WT; Figure 3 ). Moreover, the bicalutamide treatment does not have any effect on WT intact mice (23.1±2.2% in WT mice) when compared with the intact WT male mice (in Figure 1C , 26.3±3.9%), indicating that E2 is effective in this mice.
These data strongly support the role of AR action on the protective effect of testosterone.
Sex Steroid Hormone Treatment Increases Skin Flap Reperfusion
Revascularization is one of the main responses to ischemia. We next studied the effects of the sex hormones (testosterone, E2, and dihydrotestosterone) on skin revascularization, using laser Doppler perfusion imaging on FVB mice ( Figure 4A and 4B). Surgery induced severe ischemia of the flap in the immediate postoperative period, at similar levels in all groups of mice (0.58±0.01, 0.68±0.04, 0.75±0.02, and 0.73±0.03 perfusion units for castrated, E2-, testosterone-, and dihydrotestosterone-treated animals, respectively) even though the effect of surgery in the reduction of blood flow was not strongly visible on E2-treated mice. The restoration of blood flow started from the proximal part of the flap. This was reduced in castrated mice, with a perfusion that remained lower at days 6 and 8 compared with the perfusion observed in all of the sex hormone-treated mice (0.74±0.07 and 0.92±0.06 perfusion units in castrated mice on days 6 and 8, respectively). Reperfusion was maximal at day 6 post-surgery in animals treated with testosterone and dihydrotestosterone (1.37±0.19 and 1.41±0.08 perfusion units, respectively) and at day 8 in E2-treated mice (1.57±0.1 perfusion units). Moreover, the laser color Doppler images clearly show visible vessels in these animals at day 6 when the revascularization is almost complete, whereas the images of the large arteries are a little fuzzy in E2-treated mice. There was no statistically significant difference between the different hormonal treatments used. However, revascularization of the skin flap was faster in dihydrotestosteronetreated mice and slightly delayed in animals treated with E2, with the maximum value observed at day 8.
Our angiogram results were consistent with the laser Doppler images we obtained ( Figure 4C, lower) . Arteriolar anastomoses were also observed on gross examination of the skin ( Figure 4C, upper) . These occurred at the pedicle section on the proximal part of the flap when blood flow was disturbed. Arteriolar remodeling seemed to be more efficient in dihydrotestosterone-treated mice (arrow) compared with E2-or testosterone-treated mice. Conversely, there was more suffusion bleeding in the distal part of the flap in castrated mice. These hemorrhages were significantly attenuated or absent in treated animals, regardless of hormone treatment.
Altogether, these data demonstrate that sex hormones, either E2, testosterone, or dihydrotestosterone, promote skin revascularization, with a slightly higher efficiency of dihydrotestosterone treatment in male mice.
Hormonal Treatment Increases Mesenteric Arteriogenesis
Arterial remodeling is one of the major processes involved in postischemic revascularization. Gross examination of the top of the skin flap suggested that this remodeling was more efficient in male mice treated with dihydrotestosterone. To better quantify this arteriogenesis, we then analyzed flow (shear stress)-mediated outward remodeling of the resistance arteries in male rats. To do so, rats were either left intact or castrated and treated or not with E2 or dihydrotestosterone before being submitted to surgery to increase local blood flow in 1 mesenteric artery in vivo ( Figure 5 ). Arteries were then collected after 14 days for flow-mediated arterial remodeling analysis because remodeling was achieved at that time. The seminal glands were also weighed and confirmed the efficiency of the hormonal treatment (524±0.079 mg for dihydrotestosterone-treated mice versus 37±0.006 and 42±0.011 mg for CSX and CSX+E2, respectively; Figure III in the online-only Data Supplement). Fourteen days after ligation, arterial diameter was significantly increased in high-flow (HF) arteries compared with normal flow control arteries ( Figure 5A) . The difference between HF and normal flow arteries was measured as a percentage of the increase in diameter (HF versus normal flow artery). Arterial diameter was significantly increased in the HF arteries in intact male rats ( Figure 4A) ; however, this enlargement was lost in castrated rats ( Figure 5B) , showing that sex hormones are involved in arterial remodeling. Treatment with E2 or dihydrotestosterone ( Figure 5C and 5D) significantly increased the arterial diameter in HF compared with normal flow arteries. This arterial remodeling was increased from 14.3±0.7% in castrated males to 28.7±1% in intact males and 25.5±1.8% and 27.8±1.6% in E2-and dihydrotestosterone-treated males, respectively ( Figure 5E and 5F). A small difference between E2 and dihydrotestosterone was observed but was not significant. Both E2 and dihydrotestosterone thus triggered an efficient blood flow-induced outward remodeling in male rats.
To further characterize the mechanisms of sex hormones actions, we first analyzed the action of the enthothelial nitric oxide synthase (eNOS) which is one of the key factors in arteriogenesis. 20 Moreover, hormonal treatment with E2 or with androgens, such as testosterone or dihydrotestosterone, was found to increase expression of eNOS and production of nitric oxide (NO). 21, 22 Given the importance of the eNOS in this process, we used a pharmacological approach and treated mice with the NOS inhibitor, L-NAME (L-N G -nitroarginine methyl Figure 5 . Sex hormones induce flow-mediated outward remodeling (FMR) of resistance arteries on male rats. Arterial diameter was measured in response to stepwise increases in pressure in mesenteric arteries submitted chronically to high flow (HF) or to normal flow (NF). Arteries were isolated from wild-type male rats (intacts, A) or from castrated male rats untreated (B) or treated with E2 (C) or dihydrotestosterone (DHT; D). Mean±SEM is represented (n=12 rats per group). On E, the difference between HF and NF arteries was appreciated as a percentage increase in diameter, also called % remodeling (HF vs NF artery). Mean of % remodeling for all pressures was calculated for each treatment. Statistical significance between CSX and treatment is indicated. F, Results of 2-way ANOVA are indicated, comparing for each treatment HF versus NF arteries (A-D) or with CSX (E). On F, 1-way ANOVA was reported. *P<0.05, **P<0.01, ***P<0.001. ester). This pharmacological inhibition with L-NAME had no effect on necrosis in any hormonal treatment (E2 or dihydrotestosterone), demonstrating that the NO is not a major mediator in the protective effect of sex hormones ( Figure IV in the online-only Data Supplement).
We also performed protein analysis of cytokines on the top of the skin flap where the arteriogenesis occurred. Indeed, various types and waves of inflammatory cells are recruited to ischemic sites where they are shown to play a major role in tissue and vascular remodeling. 23 The data ( Figure IV in the online-only Data Supplement) clearly indicate an induction of granulocyte macrophage colony-stimulating factor in both E2-and dihydrotestosterone-treated animals and particularly of granulocyte colony-stimulating factor in dihydrotestosterone-treated mice at day 2. In contrast, inflammatory cytokines, such as interleukin-6 and interferon-γ, were higher induced in E2-treated mice when compared with dihydrotestosterone.
Thus, both E2 and dihydrotestosterone increase revascularization of the skin flap independently of eNOS but with subtle effects on waves of cytokines expression.
Hormonal Treatment Affects the Structure of the Skin
Numerous studies have shown that skin physiology is influenced by sex. [24] [25] [26] Therefore, the actions of sex hormones on skin structure in male mice were visualized by histology after hematoxylin-eosin staining or after staining with alcyan blue to highlight the hyaluronic acid content after each hormonal treatment ( Figure 6A ). Hyaluronic acid is an important structural component of the skin. It maintains skin moisture levels in the dermis 28 and is important for maintaining skin structural integrity. It has also been shown as fundamental for skin injury repair through its complex interactions with matrix components and cells. 29, 30 We found that castration increased both the density and size of the pilosebaceous units that were mainly present in the anagen phase of the hair growth cycle, leading to an increased skin thickness. There were also a greater number of adipocytes in the hypodermis of castrated mice compared with intact male mice. E2 treatment of castrated mice decreased the thickness of the dermis but strongly favored a mucinous layer rich in hyaluronic acid below the platysma muscle (detected by an intense blue color). The skin structures of testosterone-or dihydrotestosterone-treated mice were similar to those of intact mice. However, although the hyaluronic acid content in testosterone-treated mice was equivalent to the amount found in intact mice, probably because of its aromatization into E2, it was lower than that found in E2-treated mice. Hyaluronic acid was absent from the skin of dihydrotestosterone-treated mice. Respective protective actions of testosterone, estradiol, and dihydrotestosterone (DHT) on skin structure and skin survival. A, The skin structure of the skin was assessed by hematoxylin-eosin (H&E) staining (×100 magnification) and by Alcyan blue staining of skin flap longitudinal sections from intact and castrated C57BL/6 male mice treated or not with E2, DHT or testosterone. B, MTT assay was performed on dorsal skin samples harvested from intact Hairless male and castrated male treated or not with E2, DHT, or testosterone, immediately after animals were euthanized and after 24 and 48 h of culture in DMEM (Dulbecco Modified Eagle Medium). Skin viability was expressed as a percentage of viability measured at time 0 (considered as 100%), as previously described (Materials and Methods, Gelis et al 27 These results show that sex steroid hormone treatment affects the skin structure of male mice, with E2, testosterone, or dihydrotestosterone treatment reducing skin thickness by blocking the proliferative pilosebaceous units in the telogen phase. However, only E2 treatment also strongly increased hyaluronic acid synthesis below the plasyma muscle.
E2 Efficiently Protects Skin Viability in Contrast to Dihydrotestosterone
As previously demonstrated in females, the protective effect of E2 on skin necrosis involves not only revascularization but also skin protection, to further decrease vascular leakage and reperfusion hemorrhages. 1 Skin viability was therefore measured in male mice treated with E2, testosterone, or dihydrotestosterone, using an MTT assay on ex vivo skin explants ( Figure 6B) Altogether, these results show that hormonal treatments increased skin survival in male mice with a greater effect of E2 compared with dihydrotestosterone.
Discussion
Multiple processes have been implicated in delayed wound healing, 31, 32 and an altered balance of circulating sex steroid hormones is probably also involved, especially in the elderly. 33 Furthermore, skin physiology is also greatly influenced by sex steroid hormones. 24, 34 These data led us to explore the role of sex hormones in skin ischemia in male mice. Our results clearly show that male mice treated with E2, testosterone, or dihydrotestosterone are efficiently protected from necrosis compared with untreated animals. However, the actions of each of these hormones were substantially different, revealing the complementary actions mediated by the AR and ER.
First, our data demonstrate that E2 strongly protects male mice from skin necrosis after ischemic injury, with a similar pattern previously shown in females.
1 This is somewhat unexpected if we consider previous data concerning wound healing or other responses in ischemic tissues, where E2 has been described to accelerate wound healing in females via ERβ 6, 8 but inhibit it in male mice via ERα. 9 This apparent discrepancy between wound healing (requiring the control of inflammation, epithelialization, and remodeling) and skin flap recovery (involving skin survival and revascularization) is that the sequences of cellular events and thereby the cell signaling and gene regulation are different for these 2 processes. It should be underlined that E2 has been shown to exert numerous beneficial effects on ischemic lesions in several other tissues (brain, myocardium, and hindlimb), 35, 36 emphasizing the extent of protection that this hormone provides. Finally, whereas the beneficial effects of E2 on wound healing rely predominantly on ERβ in females, 8 the beneficial effects on skin necrosis rely on ERα in both females 1 and males (present study). This study also demonstrates that testosterone is as efficient as E2 in preventing skin necrosis in castrated male mice. This protective effect of testosterone is probably of major importance because intact male ERα-KO mice were also protected against skin necrosis. These ERα-KO male mice have a high level of circulating sex hormones, including E2, but they have particularly high levels of testosterone because of the absence of negative feedback exerted through the hypothalamic-pituitary axis. 18 The results from these ERα-KO male mice further emphasize the role of the different sex hormones, showing that although E2 does not play a role in these mice because of the absence of its receptor, testosterone is active. The role of androgens, acting through the AR, was further emphasized using the androgen inhibitor, such as bicalutamide in Ar-KO mice (that are unable to convert testosterone into estrogen). Indeed, the percentages of necrosis were increased in Ar-KO mice when compared with WT mice when the bicalutamide was used (Figure 3) , demonstrating the direct actions of androgens. Despite testosterone being the main circulating sex hormone in males, it is a rather weak agonist of AR compared with its derivative dihydrotestosterone. It is well recognized that the actions of testosterone partly depend on its conversion into (1) E2 by the enzyme CYP19 (aromatase) and (2) the more potent androgen dihydrotestosterone by the enzyme 5α-reductase. The use of dihydrotestosterone thus allows us to delineate the precise role of AR activation independently of any ER-mediated effects that are because of testosterone aromatization into E2. The present results indicate that dihydrotestosterone prevents skin flap necrosis with a similar efficiency as E2. Altogether, these data indicate that, in addition to ERα, the AR is also directly involved in the prevention of skin ischemia in male mice.
Our results on skin revascularization and angiographic investigations demonstrate that the protective effects of sex steroid hormones in males are highly correlated with an accelerated reperfusion of the skin, after the collateral remodeling of the sectioned pedicle. Dihydrotestosterone strongly increases revascularization in castrated males, and dense arterial remodeling occurs at the sectioned pedicle ( Figure 4C) . Conversely, the effect of E2 on revascularization using laser Doppler analysis is as efficient as dihydrotestosterone in the later stages (day 8), but not in the early days (day 4, Figure 4B ). The slope of reperfusion was lower in E2-treated animals compared with that of the androgen-treated group (dihydrotestosterone and testosterone, Figure 4B ). These data therefore indicate a slight but potentially meaningful difference between the effects of E2 and dihydrotestosterone on revascularization in males, suggesting that although their overall magnitude of protection is high, the mechanisms induced by each hormone differ significantly. Indeed, a sex-specific role for androgens in angiogenesis has already been reported. 15 Androgens, especially dihydrotestosterone, were shown to stimulate key angiogenic events in males but not females, as shown ex vivo in cultured endothelial cells and in vivo using a hindlimb ischemiainduced angiogenesis model in male and female mice. These sex-specific proangiogenic effects were found to be mediated by AR, HIF-1α (hypoxia-inducible factor-1α), SDF-1α (stromal cell-derived factor 1α), and KDR, and were reduced after castration but induced after dihydrotestosterone treatment. 4, 15, 37 In this study, arterial remodeling in the mesenteric arteries of male mice did not really differ between E2 and dihydrotestosterone, in contrast to the differences observed between the 2 treatments in revascularization. However, flow-mediated arterial remodeling was measured on day 14 when remodeling was achieved ( Figure 5 ). Using laser Doppler analysis, we found that the perfusion unit values between E2 and dihydrotestosterone were not so different at day 8, whereas the difference was apparent at day 4. These data suggest that AR activation can orchestrate the vascular processes that restore the skin's vascular network after injury more rapidly than ER activation can. Furthermore, our findings demonstrate the key role of both ER and AR in this process in males. Revascularization in the skin flap after vascular sectioning is mediated by the proper coordination of angiogenesis and arteriogenesis, which results in a hierarchical vascular network, assessed by laser Doppler analysis. We cannot rule out that the sex hormones modulate angiogenesis and arteriogenesis differently, via the action of distinct signaling pathways, as has already been described by Kofler and Simons. 38 Indeed, they demonstrated that neuropilin I, a VEGF (vascular endothelial growth factor) receptor, functions as a VEGFR2 (vascular endothelial growth factor receptor 2) coreceptor in angiogenesis and a modulator of VEGFR2 trafficking in arteriogenesis.
In contrast to revascularization, which seems to be faster in dihydrotestosterone-treated animals compared with E2 treatment, this study also shows that E2 has a greater influence on skin survival than dihydrotestosterone, with skin survival reduced by >45% in dihydrotestosterone-treated mice on day 2 but only 10% in E2-treated mice. An increased rate of apoptosis has been already reported in males compared with females in other cell types, such as cardiomyocytes, during myocardial ischemia. 39 Sex differences in cardiac damage after ischemic injury have also been observed, with more severe cardiac damage in intact male mice compared with intact female mice. 40 In our study, gonadectomy also reduced skin survival, confirming the role of sex steroids on skin survival in male mice. Interestingly, testosterone treatment combined both effects, producing an intermediate reduction in skin survival (30%). It is noticeable that the effect of each hormone on skin survival highly correlated with the hyaluronic acid content (revealed by blue alcyan staining) of the subcutaneous tissue, with a high content observed in E2 male treated skin, a low level for dihydrotestosterone-treated skin and again an intermediate level in testosterone-treated skin ( Figure 6 ). This correlation between the hyaluronic content and the skin survival could be one of the potential mechanisms for skin survival because this mucinous layer is known to retain water content and improves wound healing. 30 Moreover, this change in the skin structure also seemed to affect the laser Doppler analysis at the basal level in E2-treated mice because the response to hypoxia was not as visible as for the other treatments. This layer at high level might change the scattering and the absorption of the laser light on the tissue. Thus, our studies suggest that changes to the dermal structure elicited by E2, but not dihydrotestosterone, increase skin resistance to ischemic necrosis involving Figure 7 . Effects of steroid sex hormones effects against ischemia on male mice. In the males, dihydrotestosterone (DHT) acts preferentially on revascularization (via angiogeneis and arteriogenesis) and less on tissue viability. Conversely, E2 seems to have a lesser effect on the vasculature but has an important impact on the skin survival. Testosterone, which acts directly via the androgen receptor (AR) or after its aromatization via the estrogen receptor ERα, combines these vascular responses with increased skin survival to achieve a strong protective effect. skin survival independently of the impact of these hormones on vascularization. Because the pharmacological use of the NO inhibitor (L-NAME) had no impact on skin necrosis ( Figure IV in the online-only Data Supplement), the impact of these sex hormones does not involve the NO as a major mediator in the protective effect of sex hormones. However, the sex hormones might implicate respective recruitment of inflammatory cells because the production of cytokines is affected differently in E2-and dihydrotestosterone-treated mice ( Figure V in the online-only Data Supplement). Both E2 and dihydrotestosterone induced a strong production of granulocyte macrophage colony-stimulating factor, but only dihydrotestosterone induced a transient expression of granulocyte colony-stimulating factor at day 2. This latter cytokine M-CSF (macrophage colony-stimulating factor) was demonstrated to be directly involved on revascularization. op/op mice lacking M-CSF present monocytopenia and display low level of neovascularization. 41 In contrast, E2 treatment induces the higher expression of proinflammatory cytokines, such as interleukin-6 and interferon-γ as opposed to dihydrotestosterone. Interleukin-6 was considered as an indirect inducer of angiogenesis. 42 These data then further indicated that even if these sex hormones have the same effect on prevention of skin necrosis, they might implicate differently inflammatory cells.
In summary (Figure 7 ), this study shows the importance of studying the role of the sex hormones independently and in gonadectomized animals. We found that in males, dihydrotestosterone acts preferentially on revascularization and less on tissue viability, whereas E2 seems to have a lesser effect on revascularization but a marked effect on skin survival. Testosterone acts (1) directly via the AR, or more potently after the conversion into dihydrotestosterone and (2) indirectly via ERα after its aromatization to produce E2, and therefore combines the effects of these compounds on vascular and skin structure to achieve a strong protective effect. One may speculate that this strong protection against skin flap necrosis by testosterone has been selected for in mammals during evolution because male behavior is associated with more frequent fighting which leads to this kind of injury.
To conclude, this study delineates how sex hormones help to maintain skin integrity in the context of skin ischemia in male mice, selectively activating protective mechanisms through both androgenic and estrogenic actions. Together with our previous study in females, 1 this work emphasizes the fact that males and females react differently to sex hormones, a finding with potential major medical implications.
